Our results show that one of them (cl 3 protein), which is a hybrid protein of the first 81 amino acids of the viral NS 1 nonstructural protein and the HA2 subunit of viral HA, stimulated H-2-restricted, influenza virus subtype-specific secondary CTL in vitro. Furthermore, immunization of mice with cl 3 protein induced the generation of memory CTL response in vivo.
Materials and Methods
Mice. Male BALB/c mice were purchased from Charles River Breeding Laboratories, Inc. (Wilmington, MA), and used at the age of 4-5 wk.
Virus Production of lnfluenza Virus-spec~c Proteins in E. coli. Influenza virus-specific polypeptides were produced in E. coli using the expression system described previously (20) (21) (22) . Briefly, plasmids containing DNA fragments complementary to the viral RNA of A/PR/8 virus (23) were manipulated to achieve expression of the following products: (a) the NS1 nonstructural protein; (b) cl 3, the first 81 amino acids of NS1 fused to HA2; (c) A13, the first 81 amino acids of NS1 fused to the first 69 amino acids of HA2; (d) c7, the entire HA (minus the signal peptide); (e) A7, the HA1 and the first 69 amino acids of HA2; and (f) c36, the HA2 alone. The NS1 protein was purified as described previously (22) . Unlike the NS1 protein, the HA-containing polypeptides were insoluble when produced in E. coli. Therefore, after lysis of the bacteria, two 0.1% deoxycholate extractions, and one 1% Triton X-100 extraction to remove contaminating E. coli proteins, the HA-specific proteins were solubilized with 4 M urea (4°C for 30 rain). The urea was then removed by dialysis at 4°C. All proteins were stored in 50 mM Tris-I-ICl, pH 8.0, 1 mM EDTA. The purity of these products was >80%.
Immunization of Mice. Mice were immunized with ~ 1,000 plaque forming units of the virus intranasally without anesthesia. To immunize mice with a polypeptide, the solution containing 500 #g/ml of c13 protein was mixed with an equal amount of complete Freund's adjuvant, and 0.2 ml of the mixture was inoculated into mice subcutaneously. 3 wk after the primary injection, mice were given an intraperitoneal booster inoculation of 50 ug without adjuvant.
Induction of Secondary CTL In Vitro. Spleens were aseptically removed from mice immunized with the virus at least 3 wk before, and were teased through a stainless steel mesh. After lysing red blood cells by treatment with ACK lysing buffer (155 mM NH4C1, 10 mM KHCO3, and 190 mM EDTA), cells were washed and resuspended in RPMI 1640 medium containing 100 U/ml penicillin and 100 #g/ml streptomycin supplemented with 10% heat-inactivated fetal bovine serum at a concentration of 2.5-3.0 x I0 6 cells/ml. Responder cells were cultured with virus-infected syngeneic spleen cells taken from normal mice at a ratio of 10:1, or with various concentrations of peptides at 37°C for 5 d in 5% COy. CTL Assay. P815 (H-2 d) cells were used as target cells for the standard 5~Cr-release assay. Single-cell suspensions of P815 cells were infected with the desired virus at an input multiplicity of >10 PFU/cell. Immediately after inoculation of the virus, 250 #Ci of Na,~5~CrO4 (New England Nuclear, Boston, MA) was added. After incubation at 37°C for 90 rain, the target cells were washed twice with RPMI and further incubated at 37°C for 6 h. 104 ~aCr-labeled target cells were incubated with effector cells at various ratios in a 96-well, round-bottom microplate (Linbro, McLean, VA) at 37°C for 4 h. The supernatant fluid (SNF) of cultures was harvested by the aid of harvesting frames (Skatron Inc., Sterling, VA), and the radioactivities of SNF were counted in a gamma counter (Packard Instrument Co. Inc., Downers Grove, IL). Percent specific lysis was calculated as follows: percent specific lysis = (experimental release -minimum release) × 100/(maximum release -minimum release). Maximum and minimum release were obtained by incubating target cells with 10% Renex 30 solution (Ruger Chem. Co., Irvington, NJ) and medium alone, respectively.
Maintenance of CTL in Presence of lnterleukin 2 (IL-2).
In vitro-stimulated spleen cell cultures were maintained for 3 wk in RPMI 1640 containing 10% FBS, 5 × 10 -5 M 2-mercaptoethanol, and either 4% rat (Collaborative Research Inc., Lexington, MA) or 20% human (Meloy Laboratories Inc., Springfield, VA) IL-2.
Determination of Precursor Frequencies of CTL.
Precursor frequencies of influenza virusspecific CTL were determined by a limiting-dilution method (24) . Spleen cell suspensions diluted to desired concentrations were distributed into round-bottom, 96-well microplates (100 #l/well), and cultured with 106 X-irradiated (2,500 rad) syngeneic spleen cells infected with A/PR/8 virus in the presence of exogenous IL-2. At least seven dilutions of the cell suspension were prepared, and 24 wells were seeded with each dilution. After incubation at 37°C for 7 d, each well was assayed for cytotoxicity against A/PR/8 virus-infected P815 target cells (2,000 cells/well) directly, or after splitting into two replicas. Estimates of the CTL precursor frequency were calculated by an iterative procedure based on maximum likelihood analysis described by Fazekas de St. Groth (25) . Protein concentrations were 5/*g/ml and 12 #g/ml, in exp. 1 and 2, respectively. E:T (effector/target) ratios were 30:1 and 10:1. * A/PR/8 (H 1N 1)-infected syngeneic stimulator ceils.
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protein-stimulated cells was lower than that obtained with effector cells induced by virus-infected stimulator cells, the induction of CTL response by c 13 protein was found to be dose-dependent, and the killing of virus-infected target cells was H-2-restricted (not shown). Interestingly, neither c36 protein, which is HA2 alone, nor c7 protein, which is the entire HA, induced any CTL responses.
Virus Specificity of Secondary CTL Induced by c13 Protein. To determine the virus specificity of the secondary CTL induced by c13 protein, A/PR/8 virusor A/PC virus-immune spleen cells were stimulated with cl 3 protein and tested for their ability to lyse both A/PR/8 virus-and A/PC virus-infected P815 cells. As shown in Table II (Fig. 1 ). These results indicate that c13 protein induced an H1 virus subtype-specific CTL response. To know whether internal proteins of A/PR/8 virus were involved in the recognition by c l 3 protein-induced CTL, their cytotoxicity against A/X31 (H3N2) virus-infected target cells, which contain the internal proteins derived from A/PR/8 virus and the external glycoproteins from H3N2 virus, was examined. A/X31 virus-infected cells were not lysed by c13 protein-induced CTL, whereas they were lysed by A/PR/8 virus-induced CTL (Fig. 1 b) . This finding indicates that cl 3 protein-induced CTL recognize viral external glycoproteins.
Induction of CTL Memory In Vivo by c13 Protein. The observation that c13 protein was able to stimulate influenza virus-specific secondary CTL response in vitro led us to investigate whether this protein has the potential to generate memory CTL response in vivo. Mice were immunized with 50 #g of cl 3 protein 
Determination of Precursor Frequency of CTL. These results indicate that c13
protein has an ability to induce not only secondary CTL activity in vitro but also memory CTL response in vivo. Therefore, we attempted to determine the CTL precursor frequencies of c13 protein-immune mice. 1 wk after the booster inoculation with c l 3 protein, spleen cells were tested for their CTL precursor frequencies by limiting-dilution analysis. The results are contained in Table V Immunization of mice with the virus and cl 3 protein is given in the Materials and Methods. Protein concentration used for in vitro stimulation was 12.5 #g/ml. Cytotoxicity was assayed after 3 wk of in vitro culture, using E:T ratios of 10:1 and 3:1. A/PR/8 virus-immune spleen cells were cultured in limiting-dilution conditions with A/PR/8 virus-infected, syngeneic, X-irradiated spleen cells, or with c 13 protein (12.5 #g/ml) in the presence of X-irradiated, normal syngeneic spleen cells. After 7 d of incubation, the contents of each well were split into two aliquots, and their CTL activity was tested against both H 1 and H3 virus-infected target cells. The estimates were calculated as mentioned in the Materials and Methods. A/PR/8 (H 1N 1) and A/PC (H3N2) viruses were used to infect target cells in exp. 1 and 2. In exp. 3, A/BZ (H1N1) and A/BK (H3N2) viruses were used. In exp. 4, A/BZ and A/X31 virus were used as H1N1 and H3N2, respectively. * 95% confidence limit. Fig. 1 ) reflected the recognition pattern of CTL precursors at a clonal level.
II and
Discussion
In this paper, we have shown that an influenza virus-specific hybrid protein, made of the first 81 amino acids of NS1 and the HA2 subunit of viral HA, and produced in E. coli by recombinant DNA techniques, induced a secondary CTL response in vitro, and a memory CTL response in vivo.
The observation that the entire HA, the HA2 alone, and the NS1 failed to induce the secondary CTL responses raised a question concerning which portion of the cl 3 protein, the NS1 and/or the HA2, contains the determinant responsible for inducing the CTL response. To address this question, we tested the ability of cl 3 protein-induced effector cells to kill recombinant A/X31 (H3N2) virus-infected target cells, because all of the genome coding for the internal viral proteins of this virus was derived from the A/PR/8 parent virus, but the surface glycoproteins were derived from the parent H3N2 virus (26) . The observation that c13 protein-induced effector cells were cytotoxic to A/PR/8 virus-infected cells but not to A/X31 virus-infected target cells (Fig. 1 b) indicates that c 13 protein-induced H 1 subtype-specific CTL recognize the antigenic difference expressed on the external glycoproteins. These results indicate that the HA2 portion of c l 3 protein has a determinant that is recognized by CTL precursors.
It has been reported that type A influenza virus-specific CTL generated in bulk culture show a broad specificity among type A viruses (2), while subtypespecific CTL have been also described (3, 10) . The nature of the antigenic site(s) of the virus recognized by both subtype-specific and crossreactive CTL is still unclear. Recently, Braciale et al. (27) reported that influenza virus HA expressed on murine cells, using DNA-mediated gene transfer, was recognized by both subtype-specific CTL and a subset of crossreactive CTL. Although they did not show which subunit of HA was responsible for the recognition, it is conceivable that the important determinant for the subtype-specific recognition could be located on the HA2 subunit. They also showed that some crossreactive CTL clones failed to lyse HA-expressing target cells, suggesting that viral product(s) other than HA might be recognized by crossreactive CTL. Kees and Krammer (28) reported that most of their short term CTL clones were specific for internal viral components, which appears to support this idea, even though the pattern of the crossreactivity was different from that of crossreactive CTL in bulk cultures, because those clones crossreacted among the viruses sharing genes coding for internal proteins. Furthermore, the isolation of CTL clones that react with internal proteins (14) , and the observation that mouse L cells transfected with viral NP gene can serve as target cells to crossreactive CTL (29) also seem to provide evidence that the internal protein(s) are involved in the recognition by influenza virus-specific crossreactive CTL.
The frequency of CTL precursors reacting with the subtype-specific determinant on HA2 is generally lower than that obtained by stimulation with virusinfected cells, although the CTL precursor frequencies varied between experiments. These results suggest that the majority of CTL precursors recognize viral determinant(s) other than those on HA2.
The data presented in Table VI show that A/PR/8 virus-stimulated clones lysed both A/PR/8 virus-and A/PC virus-infected target cells. These observations are different from those of Kees and Krammer (28) , who reported that most CTL clones lysed only target cells which were infected with a virus that shared internal proteins with the virus used for elicitation of the response. The reason for this discrepancy is not clear; however, since they used spleen cells taken from mice 1 wk after the primary immunization, when the primary response to infection was beginning (1, 3) , it is conceivable that the specificity pattern is different from that of spleen cells obtained from animals at least 3 wk after immunization. On the contrary, our results are in accordance with those of Owen et al. (30) , who reported that ~80% of A/PR/8 virus-stimulated CTL clones lysed both A/PR/8 (H1N1) virus-and A/Northern Territory/60/68 (H3N2) virus-infected cells. As the majority of CTL clones reactive with c13 protein lysed only target cells infected with H 1 subtype viruses, it seems unlikely that fully crossreactive CTL precursors recognize conserved antigenic portions of the HA2 subunit. These results support the concept that highly conserved internal proteins are recognized by these crossreactive CTL.
Although we do not know the precise role of the first 81 amino acids of NS1, which is coupled to the HA2 in c13 protein, this region may be important for maintaining the tertiary structure of the protein, in order to present the immunodominant site to the responding cells, or for serving as an adjuvant. Since a derivative of cl 3 protein (A13 protein) lacking 153 amino acids of the carboxy terminal end of the HA2 did not stimulate a CTL response, the antigenic site may be mapped to this portion; however, we could not rule out the possibility that the failure of A13 protein to induce CTL response may be due to the change of configuration because of the removal of this portion from c 13 protein. In this respect, it seems worth pointing out that a CNBr cleavage product of HA2 (between residues 103 and 123) has been reported (12) to induce a subtypespecific secondary CTL response. The reason neither the entire HA nor HA2 alone induced a CTL response is not clear. The lack of glycosylation of these proteins may be an explanation, although it is also possible that special factor(s) may be required for the generation of CTL response by these proteins, as described by Wabuke-Bunoti et al. (31) .
In conclusion, we have shown here that an influenza virus-specific hybrid protein including the first 81 amino acids of NS1 and the HA2 subunit of viral HA, prepared by recombinant DNA techniques, can produce both an in vitro secondary CTL response and in vivo generation of memory CTL in a subtypespecific manner. Since it has been reported (32) that a subtype-specific CTL clone can protect mice from lethal infection with influenza A virus, it will be interesting to see whether this protein induces protective immunity to the recipient mice. Experiments investigating this issue are now in progress.
Summary
We have tested the abilities of various polypeptides of A/PR/8/34 (H1N1) virus, constructed by recombinant DNA techniques, to induce influenza virusspecific secondary cytotoxic T lymphocyte (CTL) responses. A hybrid protein (cl 3 protein), consisting of the first 81 amino acids of viral nonstructural protein (NS 1) and the HA2 subunit of viral hemagglutinin (HA), induced H-2-restricted, influenza virus subtype-specific secondary CTL in vitro, although other peptides did not. Using a recombinant virus, the viral determinant responsible for recognition was mapped to the HA2 portion of cl 3 protein. Immunization of mice with c13 protein induced the generation of memory CTL in vivo. The CTL precursor frequencies of A/PR/8/34 virus-and cl 3 protein-immune mice were estimated as one in 8,047 and 50,312, respectively. These results indicate that c 13 protein primed recipient mice, even though the level of precursor frequency was below that observed in virus-immune mice.
